Human ANPEP (CD13) knockout THP-1 cell lysate
Be the first to review this product! Submit a review
|
(0 Publication)
ANPEP KO cell lysate available now. KO validated by Immunocytochemistry, Western blot. Free of charge wild type control included. Knockout achieved by using CRISPR/Cas9, Homozygous: 2 bp deletion in exon 2.
View Alternative Names
AMPN_HUMAN, ANPEP, AP-M, AP-N, Alanyl (membrane) aminopeptidase, Alanyl aminopeptidase, Aminopeptidase M, Aminopeptidase N, CD13 antigen, LAP 1, Microsomal aminopeptidase, Myeloid plasma membrane glycoprotein CD13, P150, PEPN, gp150, hAPN
- WB
Lab
Western blot - Human ANPEP (CD13) knockout THP-1 cell lysate (AB275505)
Lane 1 : Wild-type THP-1 cell lysate 30 ug
Lane 2 : ANPEP knockout THP-1 cell lysate 30 ug
Lane 3 : PANC-1 cell lysate 30 ug
Lane 4 : HEK-293 cell lysate 30 ug
Lanes 1 - 4 : Merged signal (red and green). Green - ab108382 observed at 160 kDa. Red - loading control ab8245 (Mouse anti-GAPDH antibody [6C5]) observed at 37kDa.
ab108382 was shown to react with CD13 in wild-type THP-1 cells in western blot with loss of signal observed in ANPEP knockout cell line ab273759 (knockout cell lysate ab275505). Wild-type and CD13 knockout THP-1 cell lysates were subjected to SDS-PAGE. Membranes were blocked in 3% milk in TBS-T (0.1% Tween®) before incubation with ab108382 and ab8245 (Mouse anti-GAPDH antibody [6C5]) overnight at 4°C at a 1 in 1000 dilution and a 1 in 20000 dilution respectively. Blots were incubated with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-CD13 antibody [EPR4059] (<a href='/en-us/products/primary-antibodies/cd13-antibody-epr4059-ab108382'>ab108382</a>) at 1/1000 dilution
Lane 1:
Wild-type THP-1 cell lysate at 30 µg
Lane 2:
ANPEP knockout THP-1 cell lysate at 30 µg
Lane 2:
Western blot - Human ANPEP (CD13) knockout THP-1 cell line (<a href='/en-us/products/cell-lines/human-anpep-cd13-knockout-thp-1-cell-line-ab273759'>ab273759</a>)
Lane 3:
PANC-1 cell lysate at 30 µg
Lane 4:
HEK-293 cell lysate at 30 µg
Predicted band size: 109 kDa
Observed band size: 160 kDa
false
- WB
Lab
Western blot - Human ANPEP (CD13) knockout THP-1 cell lysate (AB275505)
Lane 1 : Wild-type THP-1 cell lysate 30 ug
Lane 2 : ANPEP knockout THP-1 cell lysate 30 ug
Lane 3 : PANC-1 cell lysate 30 ug
Lane 4 : HEK-293 cell lysate 30 ug
Lanes 1 - 4 : Merged signal (red and green). Green - ab108310 observed at 160 kDa. Red - loading control ab8245 (Mouse anti-GAPDH antibody [6C5]) observed at 37kDa.
ab108310 was shown to react with CD13 in wild-type THP-1 cells in western blot with loss of signal observed in ANPEP knockout cell line ab273759 (knockout cell lysate ab275505). Wild-type and CD13 knockout THP-1 cell lysates were subjected to SDS-PAGE. Membranes were blocked in fluorescent western blot (TBS-based) blocking solution before incubation with ab108310 and ab8245 (Mouse anti-GAPDH antibody [6C5]) overnight at 4°C at a 1 in 1000 dilution and a 1 in 20000 dilution respectively. Blots were incubated with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-CD13 antibody [EPR4058] (<a href='/en-us/products/primary-antibodies/cd13-antibody-epr4058-ab108310'>ab108310</a>) at 1/1000 dilution
Lane 1:
Wild-type THP-1 cell lysate at 30 µg
Lane 2:
ANPEP knockout THP-1 cell lysate at 30 µg
Lane 2:
Western blot - Human ANPEP (CD13) knockout THP-1 cell line (<a href='/en-us/products/cell-lines/human-anpep-cd13-knockout-thp-1-cell-line-ab273759'>ab273759</a>)
Lane 3:
PANC-1 cell lysate at 30 µg
Lane 4:
HEK-293 cell lysate at 30 µg
Predicted band size: 109 kDa
Observed band size: 160 kDa
false
- Sanger seq
Supplier Data
Sanger Sequencing - Human ANPEP (CD13) knockout THP-1 cell lysate (AB275505)
Homozygous : 2 bp deletion in exon 2
- WB
Lab
Western blot - Human ANPEP (CD13) knockout THP-1 cell lysate (AB275505)
Lanes 1 - 4 : Merged signal (red and green). Green - ab227663 observed at 160 kDa. Red - loading control ab8245 (Mouse anti-GAPDH antibody [6C5]) observed at 37kDa.
ab227663 was shown to react with CD13 in wild-type THP-1 cells in western blot with loss of signal observed in ANPEP knockout cell line ab273759 (knockout cell lysate ab275505). Wild-type and ANPEP knockout THP-1 cell lysates were subjected to SDS-PAGE. Membranes were blocked in 3% milk in TBS-T (0.1% Tween®) before incubation with ab227663 and ab8245 (Mouse anti-GAPDH antibody [6C5]) overnight at 4°C at a 1 in 400 dilution and a 1 in 20000 dilution respectively. Blots were incubated with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-CD13 antibody [SP187] (<a href='/en-us/products/primary-antibodies/cd13-antibody-sp187-ab227663'>ab227663</a>) at 1/400 dilution
Lane 1:
Wild-type THP-1 cell lysate at 30 µg
Lane 2:
Western blot - Human ANPEP (CD13) knockout THP-1 cell lysate (ab275505) at 30 µg
Lane 3:
PANC-1 cell lysate at 30 µg
Lane 4:
HEK-293 cell lysate at 30 µg
Secondary
Lanes 1 - 4:
Western blot - Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-irdye-800cw-preadsorbed-ab216773'>ab216773</a>) at 1/20000 dilution
Lanes 1 - 4:
Western blot - Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (<a href='/en-us/products/secondary-antibodies/goat-mouse-igg-h-l-irdye-680rd-preadsorbed-ab216776'>ab216776</a>) at 1/20000 dilution
Predicted band size: 109 kDa
Observed band size: 160 kDa,37 kDa
false
Reactivity data
Product details
Knockout cell lysate achieved by CRISPR/Cas9.
REACH authorisation
Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.
Lysate preparation: Our lysates are made using RIPA buffer to which we add a protease inhibitor cocktail and phosphatase inhibitor cocktail (ratio: 300:100:10). This means that the protein of interest is denatured. If you require a native form of the protein please use the live cell version. Please refer to our lysis protocol for further details on how our lysates are prepared.
User storage instructions: Lyophilizate may be stored at 4°C. After reconstitution, store at -20°C for short-term storage or -80°C for long-term storage.
This product is subject to limited use licenses from The Broad Institute and ERS Genomics Limited, and is developed with patented technology. For full details of the limited use licenses and relevant patents please refer to our limited use license and patent pages.
What's included?
Properties and storage information
Gene name
Gene editing type
Gene editing method
Knockout validation
Zygosity
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
CD13 regulates peptide-mediated signaling and controls the maturation and catabolism of bioactive peptides. The enzymatic function of CD13 influences processes such as cell proliferation motility and angiogenesis. It does not operate as part of a larger complex but its activity modulates several cellular and systemic functions. CD13's role in these biological processes highlights its importance in modulating local and systemic peptide pools which contributes to its diverse physiological effects.
Pathways
CD13 plays significant roles in the renin-angiotensin system and the regulation of inflammatory responses. In the renin-angiotensin system CD13 modulates the activity of angiotensin influencing blood pressure and fluid balance. Through its enzymatic activity CD13 interacts with proteins such as ACE another critical player in this pathway. In inflammation CD13 regulates the availability of chemotactic peptides affecting leukocyte migration and adhesion. The proteins it works with in inflammatory pathways include cytokines which CD13 indirectly modulates by altering chemokine activity.
Quality control
STR analysis
CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX
Cell culture
Biosafety level
EU: 1 US: 1
Adherent/suspension
Suspension
Gender
Male
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com